Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
SCOLR Pharma, Inc. (SCLR)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 817.3% | 817.3% | -1179.2% | 672.5% | 647.1% | 1484.4% | 1247.1% | 69.4% |
| Gross profit | -717.3% | -717.3% | 1279.2% | -572.5% | -547.1% | -1384.4% | -1147.1% | 30.6% |
| Sales and marketing | 30.9% | 20.7% | 70.3% | 47.5% | 35.7% | 45.1% | 48.8% | 7.3% |
| Research and development | 260.2% | 260.2% | 654.3% | 394.0% | 337.6% | 925.1% | 589.0% | 6.1% |
| General and administrative | 526.2% | 536.4% | 454.7% | 231.0% | 273.8% | 514.2% | 609.3% | 63.6% |
| Depreciation | 42.1% | 42.1% | 43.8% | 20.4% | 15.5% | 52.7% | 58.1% | 7.4% |
| EBIT | -717.3% | -717.3% | -663.5% | -572.5% | -547.1% | -1384.4% | -1147.1% | -46.4% |
| Pre-tax income | -734.7% | -716.3% | -640.9% | -538.5% | -471.5% | -1398.5% | -1300.4% | -132.6% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -734.7% | -716.3% | -640.9% | -538.5% | -471.5% | -1398.5% | -1300.4% | -132.6% |
|